|
|
|
30.03.26 - 08:31
|
GSK Announces Approval For Exdensur In China (AFX)
|
|
|
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - GSK plc (GSK, GSK.L) announced that China's National Medical Products Administration has approved Exdensur or depemokimab as add-on maintenance treatment of se......
|
|
|
30.03.26 - 08:12
|
Fears of Widening Iran War Grow | The China Show 3/30/2026 (Bloomberg)
|
|
|
“Bloomberg: The China Show” is your definitive source for news and analysis on the world's second-biggest economy. From politics and policy to tech and trends, David Ingles and Yvonne Man give global investors unique insight, delivering in-depth discussions with the newsmakers who matter. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.03.26 - 07:24
|
China′s ′teapot′ oil refineries keep economy brewing – but surging crude prices leave them strained (The Guardian)
|
|
|
The factories, which buy cheap crude and turn it into fuel, are struggling as higher oil prices threaten their razor-sharp margins The towns that are the bulwark of China's energy security can, at a moment of global crisis, appear deceptively quiet. Trucks carrying oil trundle along wide-open highways that have little traffic, while a few boarded-up shops in crumbling low-rise buildings hint at a long-forgotten local buzz.A ramshackle noodle shop serving hand-pulled ribbons of dough was empty at lunchtime, save for a few construction workers and a teacher watching videos on Douyin, the social media platform, with his meal. Continue reading......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.03.26 - 05:19
|
Innovent Biologics Bullish on China Obesity Drug Outlook (Bloomberg)
|
|
|
Innovent Biologics has reported its first profit even as competition from weight-loss generics looms. Speaking exclusively to Bloomberg's "The China Show," CFO Rachel You says China's obesity drug market has massive potential and could mirror current penetration rates in the US. (Source: Bloomberg)...
|
|
|
30.03.26 - 04:48
|
Chinese company to use AI-powered chromosome testing to boost profits and fast track IVF (SCMP)
|
|
|
Biotech firm Hangzhou Diagens Biotechnology is banking on AI-powered chromosome testing to drive profit growth following its Hong Kong listing, as China's falling fertility rate spurs demand for assisted reproduction.
“In China, many young people do not want to marry or have children, and by the time they decide to start a family, they need medical help to do so,” Diagens' founder and executive director, Song Ning, said.
“We are meeting an increasing number of couples every year who struggle to......
|
|
|
|
|
30.03.26 - 04:06
|
What makes Yuanjie – a Chinese optical chip star and Hong Kong IPO candidate – stand out? (SCMP)
|
|
|
Yuanjie Semiconductor Technology, a Chinese maker of laser chips for optical communications, has emerged as one of the mainland exchanges' biggest beneficiaries of the artificial intelligence infrastructure boom – with its shares rising nearly ninefold over the past year as it pursues a Hong Kong listing.
The Shaanxi-based integrated device manufacturer, whose shares closed at 1,100 yuan on Friday, now ranks second by share price among mainland-listed companies, trailing only Kweichow Moutai at......
|
|
|
|
Top- News zu China 14641.102 +0.93% (China A50 Kurs)
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
